Full Length Research Paper
References
|
Abotchie PN, Shokar NK (2009). Cervical cancer screening among college students in Ghana.Knowledge and health beliefs. International Journal of Gynecologic Cancer 19:412-416, 128. |
|
|
Baldwin MK, Jensen JT (2013). Contraception during the perimenopause. Maturitas 76(3):235-242. |
|
|
Banura C, Franceschi S, van Doorn LJ (2008). Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala Uganda. International Journal of Cancer 123:2180-2187. |
|
|
Barut MU, Kale A, KuyumcuoÄŸlu U, Bozkurt M, AÄŸaçayak E, Özekinci S, Gul T (2015). Analysis of sensitivity, specificity, and positive and negative predictive values of smear and colposcopy in diagnosis of premalignant and malignant cervical lesions. Medical science monitor. International Medical Journal of Experimental and Clinical Research 21:3860. |
|
|
Bertram CC (2004). Evidence for practice: oral contraception and risk of cervical cancer. Journal of the American Academy of Nurse Practitioners 16(10):455-461. |
|
|
Bessesen MT, Adams JC, Radonovich L, Anderson J (2015). Disinfection of reusable elastomeric respirators by health care workers.A feasibility study and development of standard operating procedures. American Journal of Infection Control 43(6):629-634. |
|
|
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018). Cancer of the cervix uteri. International Journal of Gynecology and Obstetrics 143:22-36. |
|
|
Bingham A, Bishop A, Coffey P, Winkler J, Bradley J, Dzuba I, Agurto I (2003). Factors affecting utilization of cervical cancer prevention services in low-resource settings. SaludPublicaMex 3:S408-416. |
|
|
Bradley CJ, Given CW, Roberts C (2004).Health care disparities and cervical cancer. American Journal of Public Health 94(12):2098-2103. |
|
|
Bruni L, Barrionuevo-Rosas L, Serrano B, Brotons M, Cosano R, Muñoz J, Bosch FX, de Sanjosé S, Castellsagué X (2014). Human papillomavirus and related diseases in Uganda.Summary report 2014.HPV Information Centre. |
|
|
Camargo M, Soto-De Leon DC, Sanchez R, Perez-Prados A, Patarroyo ME, Patarroyo MA (2011). Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Annals of Epidemiology 21:204-213. |
|
|
Canepa M, Patel NR, Garcia-Moliner ML (2019).Pathology and Molecular Diagnosis of Cervical Cancer and Precursor Lesions.Uterine Cervical Cancer. Clinical and Therapeutic Perspectives 61:87. |
|
|
Cheesbrough M. (2006). District laboratory practice in tropical countries. Cambridge University Press 60:64. |
|
|
Chokunonga E, Levy LM, Bassett MT (2013).Zimbabwe National cancer registry.2010 Annual Report. Harare. |
|
|
Collins SI (2010). An investigation of the natural history of early cervical human papillomavirus infection and its relationship to the acquisition of epithelial abnormalities of the cervix (Doctoral dissertation, University of Birmingham). |
|
|
Cook LS, Koutsky LA, Holmes KK (1994).Circumcision and sexually transmitted diseases. American Journal of Public Health 84(2):197-201. |
|
|
Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J (2000).Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected. British journal of Cancer 83(11): 1565-72. |
|
|
Denny LA, Franceschi S, de Sanjose S, Heard I, Moscicki AB, and Palefsky J (2012). Human papillomavirus, human immunodeficiency virus and Immunosuppression. Vaccine 5:168-74. |
|
|
de Oliveira CM, Fregnani JH, Carvalho JP, Longatto-Filho A, Levi JE (2013). Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil. BMC Cancer 13:357. |
|
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Bray F (2015). Cancer incidence and mortality worldwide. International Journal of Cancer 136(5):359-386. |
|
|
Forhan SE, Godfrey CC, Watts DH, Langley CL (2015). A Systematic Review of the Effects of Visual Inspection with Acetic Acid, Cryotherapy, and Loop Electrosurgical Excision Procedures for Cervical Dysplasia in HIV-Infected Women in Low- and Middle-Income Countries. Journal of Acquired Immune Deficiency Syndromes (1):350-356. |
|
|
Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, and Ferlay J (2013). Cancer Incidence in Five Continents Volume X. IARC Scientific Publication No. 164. |
|
|
Holmes RS, Hawes SE, Touré P, Dem A, Feng Q, Weiss NS, Kiviat NB (2009). HIV Infection as a Risk Factor for Cervical Cancer and Cervical Intraepithelial Neoplasia in Senegal. Cancer Epidemiology, Biomarkers and Prevention 18(9):2442-2446. |
|
|
ICO Information Centre on HPV and Cancer (HPV Information Centre) (2016). Human Papillomavirus and Related Diseases Report: Uganda [Internet]. 2016. |
|
|
Kaku M, Mathew A, Rajan B (2008). Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India. Asian Pacific Journal of Cancer Prevention 9(4):589-594. |
|
|
Katahoire AR, Jetta J, Arube-Wani J, Kivumb G, Murokora D, Siu G,Arinaitwe L, Lyazi I (2007). Formative research report, An assessment of thereadiness for introduction of a cervical cancer vaccine in Uganda. Kampala, Child Health and Development Centre, Makerere University, 2008PATH. |
|
|
Ludwig JA, Weinstein JN (2005). Biomarkers in cancer staging, prognosis and treatment selection. Nature Reviews Cancer5 (11):845. |
|
|
Mark J, Morrell K, Alfiero A, Frederick PJ (2018). Expert Review of Cervical Cytology. Journal of Lower Genital Tract Disease 22(2):120-122. |
|
|
Mitchell SM, Pedersen HN, Sekikubo M, Moses E, Mwesigwa D (2017). Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda. A descriptive analysis of knowledge intentions to screen and factors associated with HPV positivity. BMC Womens Health 17(1):4. |
|
|
Moodley JR (2006). HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer 6:135. |
|
|
Mosciki A, Hill N, Powel K (2001). Risk for incident human papillomavirus infection and low-grade squamous intraepithelial lesions development in young females.JAMA 285:2995-3002. |
|
|
Mukama T, Ndejjo R, Musabyimana A, Halage AA,Musoke D (2017). Women's knowledge and attitudes towards cervical cancer prevention: a cross sectional study in Eastern Uganda. BMC Women's Health17(1):9. |
|
|
Muñoz N, Bosch FX, Castellsagué X (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. International Journal of Cancer 111:278-285. |
|
|
Mutyaba T, Faxelid E, Mirembe F, Weiderpass E (2007). Influences on uptake of reproductive health services in Nsangi community of Uganda and their implications for cervical cancer screening. Reproductive Health 4:4. |
|
|
Mutyaba T, Mmiro FA, Weiderpass E (2006). Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda. BMC Medical Education 6(1):13. |
|
|
Nakisige C, Melissa S, Anthony ON (2017). Cervical cancer screening and treatment in Uganda. Gynecologic Oncology Reports 20:37-40. |
|
|
Nayar R, Wilbur DC (2015). The Bethesda system for reporting cervical cytology.definitions, criteria, and explanatory notes. Springer. |
|
|
Ndejjo R, Mukama T, Musabyimnana A, Musoke D (2016). Uptake of cervical cancer screening and associated factors among women in rural Uganda. PLoS ONE 11(2):0149696. |
|
|
Parkin DM, Ferlay J, Hamdi-Cherif M (2003). Cancer in Africa: epidemiology and prevention. Lyon: IARC Press. |
|
|
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002). Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155, Lyon, IARC. |
|
|
Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CG. Nayama M (2004). Accuracy of visual screening for cervical neoplasia: Results from an IARC multi-center study in India and Africa. International Journal of Cancer 110(6):907-913. |
|
|
Santesso N, Mustafa RA, Schünemann HJ, Arbyn M, Blumenthal PD, Cain J, Forhan SE (2016). World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screenâ€andâ€treat strategies to prevent cervical cancer. International Journal of Gynecology and Obstetrics 132(3):252-258. |
|
|
Sapkota B, Gupta GK, Mainali D (2014). Impact of intervention on healthcare waste management practices in a tertiary care governmental hospital of Nepal. BMC Public Health 14(1):1005. |
|
|
Schmuz R, Okong P, deVilliers EM (1989). Multiple infections in case of cervical cancer for high incidence area in tropical Africa. International Journal of Cáncer 43:805-9. |
|
|
Singhal U, Lamba S, Kumar U, Nanda A (2018). Pattern of Epithelial Cell Abnormalities On Cervical Papanicolaou Smears In Hospital Of North India. Annals of Pathology and Laboratory Medicine 5(3):A250-255. |
|
|
Stanley M (2010). Pathology and epidemiology of HPV infection in females. Gynecologic Oncology 117(2):5-10. |
|
|
Szaba R, Short RV (2000). How does circumcision protect against HIV infections? British Medical Journal10; 320(7249):1592-4 |
|
|
Tobian A, Serwadda D, Quin TC (2009). Male circumcision for prevention of HSV-2 and HPV infections and Syphilis. New England Journal of Medicine 360:1298-309. |
|
|
Uganda Bureau of Statistics (UBOS), Health planning in Uganda (2015).Carey RB, Bhattacharyya, S, Kehl SC, Matukas LM, Pentella MA, Salfinger M, Schuetz AN (2018).Implementing a quality management system in the medical microbiology laboratory. Clinical Microbiology Reviews 31(3):62-17. |
|
|
Wabinga HR, Nambooze S, Amulen PM, Okello C, Mbus L,Parkin DM (2014). Trends in the incidence of cancer in Kampala, Uganda 1991-2010. International Journal of Cancer 135(2):432-439. |
|
|
Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S (2000).Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. British Journal of Cancer 82(9):1585. |
|
|
Walker ARP, Michelow PM, Walker BF (2002).Cervix cancer in African women in Durban, South Africa. International Journal Gynecology and Obstetrics 79:45-46. |
|
|
World Health Organization (WHO) (2014). Cervical cancer, human papillomavirus (HPV), and HPV vaccines: key points for policy-makers and health professionals. Geneva: WHO 2007. [21 November 2014]. |
|
|
Wideroff SM, Haderer P (1999). Seroreactivity to human papillomavirus type, 16, 18, 31 and 45 virus-like particles in a case control study of cervical squamous intraepithelial lesions. Journal of Infectious Diseases 180:1424-28. |
|
|
Kharbanda P, Singh DK, Anand R, Singh A (2015). Study of awareness amongst women in rural and urban areas about early detection of cervical cancer by Pap smear. Indian Journal of Pathology ad Oncology 2(4):219-29. |
|
|
WMA (2000). World Medical Association Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects, (e52ndWMA General Assembly, Edinburgh, Scotland, 2000. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
